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sure target. Guidelines aim to assist clinicians in the management of patients with hypertension.
Objectives: The primary purpose of the study was to survey family physicians(FPs) in Kuwait
about their awareness, and to understand better their reasons for not implementing speciﬁc
guidance within the WHO/ISH guidelines.
Methods: This study is a cross-sectional survey that was carried out in the ﬁve health regions of
Kuwait. All PHC physicians who were currently working as FPs were asked to participate in the
study. Data were collected using a structured questionnaire of clinically oriented questions formu-
lated on the basis of the 1999 World Health Organization/International Society of Hypertension
(WHO/ISH), as standard reference.
Results: The study revealed that 49.1% and 42.1% of FPs were very familiar or somewhat familiar
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82 K.A. Al-Ali et al.usually follow these guidelines when treating patients. Regarding the correct choice of the guideline
statements, only 8.8% of the FPs choose correctly less than ten of the 20 statements, 64% choose 10
to less than 15, and only 27.2% choose P 15 statements. When asked about perceived patient
barriers to blood pressure control, 84.0% of the respondents ranked overcrowded clinics as impor-
tant or most important barrier to blood pressure control while, 87.4% considered lack of patient
knowledge as important or most important barrier. Non availability of the drugs in the clinic
was considered by 88.4% of the physicians, and poor adherence to antihypertensive drugs by
90.1%.
Conclusion: There is a need to establish nationwide educational and quality monitoring programs
to facilitate the correct implementation of hypertension guidelines in PHC clinical practices in
Kuwait.
ª 2012 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. All rights
reserved.1. Introduction
Hypertension is the number one risk factor for mortality in the
world and an important risk factor for cardiovascular disease
and stroke.1–3 Hypertension is typically diagnosed and man-
aged in the outpatient setting and is one of the most common
reasons to visit a family physician (FP).4 With almost a quarter
of the adult population and almost half of people aged
50 years and older having hypertension, the burden of this dis-
ease is undeniably high.5 As treatment of hypertension is asso-
ciated with a 20% to 25% reduction in cardiovascular events,6
getting control of this generally asymptomatic disease might be
one of the most important preventive measures that FPs can
take.4,6
Despite incontrovertible scientiﬁc evidence that lowering
blood pressure (BP) is markedly effective in reducing cardio-
vascular disease events, as pointed out in all major guidelines
on hypertension management,7,8 arterial hypertension is
known to be poorly diagnosed and treated in general practi-
ce.9In developed countries, the proportion of hypertensive pa-
tients with well-controlled BP is generally less than 30%.10,11
Appropriate antihypertensive treatment is rarely implemented
even in high-risk patients, in whom BP reductions can induce
quite large life-saving effects.12
This unsatisfactory BP control among treated hypertensive
subjects has multiple causes, among which physician’s
behavior and patient’s compliance have received particular
attention.13 Although FPs are often criticized for not following
clinical practice guidelines closely and for failing to meet treat-
ment targets for many conditions, there is strong evidence that
they have made great strides in screening for and diagnosis and
treatment of hypertension.4 However, FPs adherence to evi-
dence-based medicine and to guidelines recommendations on
effective BP control has never been fully investigated.
The primary purpose of the study was to survey FPs in
Kuwait to study their awareness, and to understand better
their reasons for not implementing speciﬁc guidance within
the WHO/ISH guidelines.
2. Subjects and methods
2.1. Setting
The health care system in Kuwait is divided into ﬁve regional
health regions. Primary health care (PHC) is provided by 80centers served by 157 family physicians (FPs) and 489 general
practitioners (GPs). The study was carried out in the primary
health care centers located in all health regions of Kuwait from
October to December 2008.
2.2. Study design
An observational cross-sectional study design was adopted for
this study. All available 157 FPs during the ﬁeld work period
of the study were the target population of this study. Out of
them, only 114 agreed to share in the study with an overall
response rate of 72.6%.
Data were collected using a structured self-administered
questionnaire of clinically oriented questions formulated on
the basis of the 1999 WHO/ISH, as standard reference.9,10
The questionnaire consisted of three parts. The ﬁrst part
includes personal characteristics (age, gender, nationality,
duration of work in PHC, specialty, average number of
hypertensive patients seen per week). In the second part,
questions were related to familiarity, agreement, following
WHO/ISH guidelines. It consisted of 20 guideline statements
and scenarios that explored the level of knowledge and
agreement with (WHO/ISH) guidelines as well as implemen-
tation of these guidelines. The ﬁrst 10-items were developed
focusing on diagnostic issues (four questions), pharmacolog-
ical treatment (three questions), therapeutic strategies (two
questions) and target BP (one question). Another 10 multi-
ple-choice questions included one speciﬁc answer in order
to offer the physician an opportunity to choose the correct
one. The last part includes 6 questions related to barriers
for improving their hypertensive patient management. Physi-
cians were asked to pick only one answer for each question
within 5 min without guessing or discussing the answer with
other colleagues.
A pilot study was carried out on 20 FPs. This study was for-
mulated to test the clarity, applicability of the study tools,
accommodate the aim of the work to actual feasibility, identify
the difﬁculties that may be faced during the application. Also,
the time needed for ﬁlling the questionnaire by the staff was
estimated during this pilot study. The necessary modiﬁcations
according to the results obtained were done.
All the necessary approvals for carrying out the research
were obtained. The Ethics Committee of the Kuwaiti Ministry
of Health approved the research. A written format explaining
the purpose of the research was prepared and signed by the
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pose and importance of the research were discussed with the
director of the health center. In order to maintain conﬁdential-
ity, questionnaires were made anonymous.
3. Statistical analysis
The Statistical Package for Social Sciences (SPSS-17) was used
for data processing. Simple descriptive statistics were used
(mean + standard deviation for quantitative variables, and
frequency with percentage distribution for categorized
variables).
4. Results
Table 1 describes the characteristics of participating FPs. Their
mean age was 36.9 ± 6.8 years ranged from 25 to 52 years,
about 62.3% of them were above 35 years of age. Females
were predominating males (68.4% versus 31.6%). Most of
the FPs (85.1%) were Kuwaiti and slightly more than half
(51.8%) of them had 10 or more years of experience as PHC
physicians. About one ﬁfth (22.8%) of FPs examined less than
20 patients per week, 43.9% examined from 20 to 39 patients,Table 1 Characters of participating doctors and their work
features.
Characteristics No. %
Age (year)
<35 43 37.7
35 53 46.5
45+ 18 15.8
Gender
Males 36 31.6
Females 78 68.4
Nationality
K 97 85.1
NK 17 14.9
Experience (year)
<5 24 21.1
5–10 31 27.2
>10 59 51.8
Average patients seen per week
<20 26 22.8
20–39 50 43.9
40–59 25 21.9
60–79 7 6.1
80+ 6 5.3
Familiar with WHO/ISH guidelinesa
Yes very familiar 56 49.1
Yes somewhat familiar 48 42.1
No 10 8.8
Agreement with WHO/ISH guidelines
Yes 105 92.1
No 9 7.9
Following WHO/ISH guidelines
Always 27 23.7
Usually 64 56.1
Sometimes 17 14.9
Rarely or never 6 5.3
Total 114 100.0
a ISH= International society of hypertension.another one ﬁfth (21.9%) examined 40 to 59 patients and
11.4% examined 60 or more patients.
Concerning the new WHO/ISH guidelines, 49.1% and
42.1% of the participants stated that they were very familiar
or somewhat familiar with the guidelines respectively and only
8.8% were not familiar with these guidelines. However, 92.1%
mentioned that they were in agreement with WHO/ISH guide-
lines. More than three quarters (79.8%) of the FPs indicated
that they always or usually follow these guidelines when
treating patients, 14.9% indicated the use of these guidelines
sometimes, and 5.3% rarely or never used them when treating
patients.
Table 2 illustrated the proportion of FPs who answered
correctly each of 20 statements related to the WHO/ISH guide-
lines. When they were asked about BP values that deﬁne el-
derly (>65 years) as hypertensive after repeated measures,
71.1% mentioned correctly the value P 140/90 mm Hg. Only
15.8% chose correctly the appropriate examinations to be
prescribed for the minimum diagnostic work-up of hyperten-
sive patients. 13.2% choose 125/80 mm Hg as correct choice
when asked about the upper normal value for self-measured
BP in hypertensive patients on antihypertensive treatment.
However, 92.1% of the physicians correctly deﬁne ‘‘white
coat’’ or isolated clinic hypertension as high ofﬁce BP, normal
ambulatory BP measurement, and normal self-measured BP.
When the physicians were asked about the duration of stay
out of pharmacological treatment for an asymptomatic patient
with recently diagnosed grade I hypertension, and no other
risk factors only 37.7% choose 6 months as a correct answer.
Blood pressure measurement (<130/80 mm Hg) was cor-
rectly selected by 66.7% of the physicians as target BP to be
reached in a hypertensive diabetic patient and Angiotensin
receptor blocker was correctly selected by only 43.0% of the
physicians as the most appropriate antihypertensive drug class
for a 50-year old, grade I hypertensive patient with left ventric-
ular hypertrophy in the echocardiogram. Angiotensin convert-
ing enzyme (ACE) inhibitor was correctly selected by the
majority of physicians (93.0%) as the most appropriate antihy-
pertensive drug class for a hypertensive patient with diabetic
nephropathy.
In response to the question, ‘‘which is the drug of third
choice for an essential hypertensive patient whose BP is
partially controlled by an ACE inhibitor plus calcium-antago-
nist?’’ 79.8% of the physicians correctly identiﬁed diuretics.
Half of FPs completed correctly the statement stated ‘‘A low
dose Aspirin for primary prevention in hypertension should
be prescribed to:’’ as hypertensive patients with BP well con-
trolled by treatment and at high cardiovascular risk.
The correct answers regarding the lowest systolic and dia-
stolic BP (<130/<80 mm Hg) at which pharmacological treat-
ment should be started to patients with co-morbidity were
reported correctly by 57% and 40.4%, respectively. The corre-
sponding proportions of FPs were 94.7% and 72.8% in case of
the lowest systolic and diastolic blood pressure at which they
would recommend pharmacologic treatment for those without
co-morbidity (6140 mm Hg for systolic and 6 90 mm Hg for
diastolic).
The majority of physicians (86.8%) considered the target
systolic BP should be 6 130 mm Hg and 83.3% considered
the target diastolic BP should be 6 80 mm Hg during pharma-
cological therapy for patients with co-morbidity as recom-
mended by WHO-ISH while 72.8% and 95.6% respectively
Table 2 Number of physicians with correct answers regarding the WHO/ISH guidelines.
Answers to ten awareness guidelines’ questions No. (114) %
1. BP values deﬁne elderly (>65 years) as hypertensive after repeated measures 81 71.1
2. Appropriate examinations to be prescribed for the minimum diagnostic wok-
up of hypertensive patients
18 15.8
3. The upper normal value for self-measured BP in hypertensive patients on
antihypertensive treatment
15 13.2
4. Deﬁnition of ‘‘white coat’’ or isolated clinic hypertension 105 92.1
5. Duration of asymptomatic patient with recently diagnosed grade I
hypertension, and no other risk factors stay out of pharmacological treatment.
43 37.7
6. The target BP to be reached in a hypertensive diabetic patient 76 66.7
7. The most appropriate antihypertensive drug class for a 50- year old, grade I
hypertensive patient with left ventricular hypertrophy at the echocardiogram
49 43.0
8. The most appropriate antihypertensive drug class for a hypertensive patient
with diabetic nephropathy
106 93.0
9. The drug of third choice for an essential hypertensive patient whose BP is
partially controlled by an ACE inhibitor plus calcium-antagonist
91 79.8
10. A low dose Aspirin for primary prevention in hypertension should be
prescribed for:
57 50.0
11. The lowest SBP at which the physician recommended pharmacotherapy to
patient With co-morbidity(<=130)
65 57.0
12. The target SBP the physician would like to achieve for patient With co-
morbidity(<=130)
99 86.8
13. The lowest DBP at which the physician recommended pharmacotherapy to
patient With co-morbidity(<=80)
46 40.4
14. The target DBP the physician would like to achieve for patient With co-
morbidity(<=80)
95 83.3
15. The lowest SBP at which the physician recommended pharmacotherapy to
patient without co-morbidity(<=140)
108 94.7
16. The target SBP the physician would like to achieve for patient Without co-
morbidity(<=140)
83 72.8
17. The lowest DBP at which the physician recommended pharmacotherapy to
patient Without co-morbidity (<=90)
83 72.8
18. The target DBP the physician would like to achieve for patient Without co-
morbidity (<=90)
109 95.6
10. First line drug choice for a patient aged 40 years, BP 150/95 with no
compelling indications and no co-morbidity
46 41.8
20. The action taken for hypertensive patient on mono-therapy with
uncontrolled BP for the last 6 months
89 84.8
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the target diastolic BP should be 6 90 mm Hg for patients
without co-morbidity.
Regarding the use of antihypertensive drugs when physi-
cians were speciﬁcally asked about the most appropriate
ﬁrst-step drug for patients who were 40 years old, with BP
150/95 with no contraindication, and with no co-morbidity,
41.8% preferred Thiazide-diuretic as the ﬁrst-line treatment.
84.8% of the physicians indicated that addition of second anti-
hypertensive drug was necessary if mono-therapy had failed to
control BP below the target level for the last 6 months.
Fig. 1 summarizes the proportion of FPs that answered cor-
rectly each of the 20 guideline statements. The mean value of
the overall score was 12.8 ± 2.7 statement with a range of zero
to 19 choices. Only 8.8% of the FPs choose correctly less than
ten of the 20 statements, 64% choose 10 to less than 15, and
only 27.2% choose P 15 statements, no one choose correctly
all the 20 statements.
Table 3 shows perceived physicians’ barriers to BP control.
Poor patient compliance to life style modiﬁcations was on the
top of the list as 95.4%ofFPs considered it as important ormostimportant. This was followed by poor adherence to
antihypertensive drugs (90.1%). Non availability of the drugs
in the clinic was considered as important ormost important bar-
rier to blood pressure control by 88.4%of the physicians, lack of
patient knowledge (78%), overcrowded clinic and lack of time
(84%), and ﬁnally follow up by different physicians (79.5%).
5. Discussion
The prevention and management of hypertension are major
public health challenges. If the rise in BP with age could be
prevented or diminished, much of hypertension-related cardio-
vascular, renal disease and stroke might be prevented.14,15
The present study indicated that FPs did not fully adhere to
all hypertension guidelines despite that 92.1% of them agreed
to apply. Only 49.1% of the participants were very familiar
with WHO/ISH guidelines and only 23.7% always follow
them. In agreement with that, in a survey of 1878 Canadian
physicians, only 52% reported that they used guidelines at
least once a month, and more than 25% expressed concerns
about the source of the guidelines, their rigidity, and the fear
Figure 1 Percentage of participants answered correctly different
numbers of statements related to the WHO/ISH guidelines.
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omy if they followed the guidelines.13
About two third of FPs deﬁned correctly the BP value as
hypertensive for elderly after repeated measures. This is in
agreement with data available from other studies using the def-
inition of high BP according to WHO/ISH guidelines re-
port.16–18 The information obtained appeared to be highly
relevant, as it documents that a large proportion of FPs has
limited familiarity with the fundamental issues dealt within
the 1999 WHO/ISH guidelines: The low or limited rate of cor-
rect answers concerning a question such as the deﬁnition of the
upper normality value of self-measured BP is related to differ-
ent normalcy thresholds reported in the major hypertension
guidelines.8,14
Regarding pharmacological treatment and therapeutic
strategies, in agreement with other studies and as recom-
mended in the 1999 WHO-ISH guidelines, diuretics are cor-
rectly chosen by 79.8% of the study FPs as a drug of third
choice for essential hypertensive patients partially controlled
by an ACE inhibitor plus calcium-antagonist. The ALLHAT
trial indicated that thiazide-type diuretics are superior to dox-
azosin, an alpha-blocker, in preventing one or more major
forms of cardiovascular disease.19 In spite of the low cost
and clearly deﬁned clinical efﬁcacy of diuretics, it was not
the ﬁrst-line drug of the physicians who participated in the sur-
vey for treatment of patients aged 40 years with no hyperten-
sion, as only 41.8% of them would initiate drug therapy with
a diuretic. Physicians may rationalize that goals are within
reach and that more time may be needed to see the effects of
therapy, reasons that are typically without pharmacological
basis.20 Psaty et al. emphasized21 that despite the various
beneﬁts of diuretics, they remain under- utilized. Ernest
reported that in spite of the fact that diuretics are superior in
the prevention of cardiovascular morbidity and mortalityTable 3 Physicians related barriers to hypertension management.
Barriers Most important
No. %
Poor patient compliance to life style modiﬁcations 70 63.6
Non adherence of patients to their medications 48 42.9
Non availability of the drugs in the clinic 52 46.4
Lack of patient knowledge 27 24.3
Overcrowded clinic (lack of time) 63 56.3
Follow up by diﬀerent physicians 42 37.5associated with hypertension, nearly 40% of the physicians
preferred to prescribe other anti- hypertensive drugs, which
suggests that diuretics still remain underused in the treatment
of hypertension.22 Moreover, studies on the prescribing pat-
terns of health care physicians revealed that most physicians
lack detailed knowledge of hypertension guidelines and tend
to prescribe more expensive drugs without evidence of
efﬁcacy.23
Based on a study in Saudi Arabia many PHC physicians in
the Aseer region lack the necessary knowledge to deﬁne and to
correctly diagnose hypertension, especially among diabetic pa-
tients.24Most PHC physicians do not adhere to the guidelines
of hypertension management. With regard to the management
of hypertensive patients with diabetes, the current study
revealed that two thirds of the FPs answered correctly that
patients with diabetes should be treated to a systolic blood
pressure < 130 mm Hg and a diastolic blood pressure
< 80 mm Hg. This was in agreement with several randomized
clinical trials that demonstrated the impact of elevated blood
pressure as a risk factor for both micro-vascular and macro-
vascular diseases in diabetes.25–27
With regard to the speciﬁc measures to improve hyperten-
sion control, 92.1% of the physicians correctly deﬁne ‘‘white
coat’’ or isolated clinic hypertension as high ofﬁce BP, normal
ambulatory BP measurement, and normal self-measured BP.
This highlights the importance of BP self- measurement for
BP control in addition to lifestyle modiﬁcation, weight reduc-
tion, sodium restriction, physical exercise, and behavioral
improvement.24
ACE inhibitor- or Angiotensin receptor blocker (ARB)-
based treatments favorably affect the progression of diabetic
nephropathy and reduce albuminuria and ARBs have been
shown to reduce progression to macro-albuminuria.28 In
agreement with that, ACE inhibitor was correctly selected by
the majority of participants (93.0%) as the most appropriate
antihypertensive drug class for a hypertensive patient with dia-
betic nephropathy.
Combinations of two or more drugs are usually needed to
achieve the target goal of < 130/80 mm Hg.29,30 Thiazide-
diuretics are beneﬁcial in reducing CVD and stroke incidence
in patients with diabetes.31 Regarding the use of antihyperten-
sive drugs and when FPs speciﬁcally asked about the most
appropriate ﬁrst-step drug for patients who were 40 years old,
with BP 150/95 with no contraindication, no co-morbidity,
41.8% preferred Thiazide-diuretic as the ﬁrst-line treatment
and 84.8% of the FPs indicated that the addition of second
antihypertensive drug was necessary if mono-therapy had failed
to control blood pressure below the target level for the last
6 months. Other study reported that most PHC physicians doImportant Less important Total
No. % No. % No. %
35 31.8 5 4.5 110 100.0
53 47.3 11 9.8 112 100.0
47 42.0 13 11.6 112 100.0
70 63.1 14 12.6 111 100.0
31 27.7 18 16.1 112 100.0
47 42.0 23 20.5 112 100.0
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sis of initial antihypertensive therapy, either alone or in combi-
nation with one of the other classes of drugs24.
The present study has found that most FPs are aware of the
recommendations of hypertension guidelines, as about 91.2%
of FPs choose correctly more than 10 statements out of 20
related to guidelines. Phillips and colleagues have proposed
that the reason for this may be due to overestimation of adher-
ence to guidelines.25
Numerous surveys have shown that about three- quarters of
all patients with hypertension do not have optimal blood pres-
sure control.9,10,32 Reviewing articles that investigated barriers
to physician’s use of clinical practical guidelines revealed that
few studies examined the full variety of barriers that may affect
the use of practice guidelines. Lifestyle modiﬁcation, such as
low salt and high potassium diet, regular exercise and weight
reduction, facilitates pharmacological control of blood pres-
sure, and should be recommended to all patients whenever
appropriate.33 Lifestyle modiﬁcation has been one of the most
frequently cited impediments to blood pressure control.34
In the present study, 97.8% of the FPs reported poor patient
compliance to life style changes to act as a barrier for BP con-
trol. Moreover, 84.5% of them ranked lack of patient knowl-
edge as most important or important barrier, 73.6 ranked
non- availability of the drug in clinic, while, 76.9% attributed
the poor control to follow up by different physicians, and
87.5% reported lack of time due to overcrowded clinics. A sur-
vey of a group of physicians in England found several barriers
to the use of hypertension treatment guidelines.35 Some physi-
cians did not think the data used for the guidelines applied to
their patients. Others did not follow the guidelines because they
thought they were outdated, they did not feel a sense of owner-
ship toward the guidelines, or they simply did not know about
them. Still others claimed that the time and ﬁnancial pressures
they felt made the treatment of hypertension and the use of
guidelines a low priority. Ironically, these seem to be the very
practitioners who should have been using the guidelines. Pa-
tient’s adherence to pharmacotherapy has been identiﬁed as
one of the main reasons for uncontrolled hypertension.10,14
Consistent with previous ﬁndings, most of our respondents
(97.8%) reported poor adherence to antihypertensive drugs as
the leading patient-related barrier to BP control. The costs of
medication and hospital visits have been identiﬁed as a major
contributing factor for poor patient adherence to pharmacolog-
ical treatment by one study. This is not the case in Kuwait as
medication is free in all PHC centres.
6. Conclusion
Several factors may account for FPs’ lack of adherence to
practice guidelines for hypertension, including knowledge def-
icits, overestimation of compliance with guidelines, disagree-
ment with guidelines, or reluctance to make therapeutic
changes. The results of this survey indicate that there is a need
to establish nationwide educational and quality monitoring
programs to facilitate the correct implementation of hyperten-
sion guidelines in PHC clinical practices in Kuwait. We
strongly urge each family physician to re-examine all patients
for hypertension and to re-examine his/her role in the detec-
tion, evaluation, management and control of hypertension.References
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